Article
Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcoma
2025-12-05
Abstract excerpt
Myeloid sarcoma, an aggressive extramedullary subtype of acute myeloid leukemia (AML), occurs in ∼10% of patients, and has not yet been included in large-scale genomic studies. The critical biological changes that drive tumor evolution are unknown, its detection in asymptomatic patients remains a clinical challenge, and treatment options are limited as patients are often excluded from clinical trials, rendering it...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- db4e09ae-5414-5dce-bfc2-d964e62eef12
- DOI
- 10.64898/2025.12.04.689069
